Search
Lineage Cell Therapeutics Inc
LCTXAdd to Watchlist
1.350USD
+0.045+3.46%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
336.55MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-02The current institutional shareholding score of Lineage Cell Therapeutics Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 46.31%, representing a quarter-over-quarter increase of 11.86%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.85% of shares outstanding, with 0.28% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
Broadwood Capital, Inc.
Chernett (Jorey)
Defender Capital LLC
Raffles Capital Management, LLC
Comerica, Inc.
BlackRock Institutional Trust Company, N.A.
Geode Capital Management, L.L.C.
1
2